Transcriptional Targeting and MicroRNA Regulation of Lentiviral Vectors.
Journal
Molecular therapy. Methods & clinical development
ISSN: 2329-0501
Titre abrégé: Mol Ther Methods Clin Dev
Pays: United States
ID NLM: 101624857
Informations de publication
Date de publication:
15 Mar 2019
15 Mar 2019
Historique:
entrez:
19
2
2019
pubmed:
19
2
2019
medline:
19
2
2019
Statut:
epublish
Résumé
Gene expression regulation is the result of complex interactions between transcriptional and post-transcriptional controls, resulting in cell-type-specific gene expression patterns that are determined by the developmental and differentiation stage of pathophysiological conditions. Understanding the complexity of gene expression regulatory networks is fundamental to gene therapy, an approach which has the potential to treat and cure inherited disorders by delivering the correct gene to patient specific cells or tissues by means of both viral and non-viral vectors. Besides the issues of biosafety, in recent years efforts have focused on achieving a robust and sustained transgene expression, which attains a phenotypic correction in several diseases, while avoiding transgene-related adverse effects, such as overexpression-associated cytotoxicity and/or immune responses to the transgene. In this sense, the use of cell-type-specific promoters and microRNA target sequences (miRTs) in gene transfer expression cassettes have allowed for a restricted expression after gene transfer in several studies. This review will focus on the use of transcriptional and post-transcriptional regulation to achieve a highly specific and safe transgene expression, as well as their application in
Identifiants
pubmed: 30775404
doi: 10.1016/j.omtm.2018.12.013
pii: S2329-0501(19)30003-8
pmc: PMC6365353
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
223-232Subventions
Organisme : European Research Council
ID : 261178
Pays : International
Références
Cell. 2000 Apr 14;101(2):173-85
pubmed: 10786833
Nat Genet. 2000 Jun;25(2):217-22
pubmed: 10835641
Blood. 2001 Jun 15;97(12):3733-7
pubmed: 11389010
Science. 2001 Oct 26;294(5543):853-8
pubmed: 11679670
Science. 2001 Oct 26;294(5543):858-62
pubmed: 11679671
Science. 2001 Oct 26;294(5543):862-4
pubmed: 11679672
Blood. 2002 Jan 15;99(2):399-408
pubmed: 11781219
Methods Enzymol. 2002;346:454-65
pubmed: 11883085
Blood. 2002 Aug 15;100(4):1133-40
pubmed: 12149189
Gene Ther. 2004 Jan;11(1):52-60
pubmed: 14681697
Blood. 2004 May 15;103(10):3700-9
pubmed: 14701690
Med Res Rev. 2004 Nov;24(6):748-61
pubmed: 15250039
Hum Gene Ther. 2005 Nov;16(11):1241-6
pubmed: 16259557
Hum Gene Ther. 2006 Mar;17(3):303-13
pubmed: 16544979
Nat Med. 2006 May;12(5):585-91
pubmed: 16633348
Gene Ther. 2007 Mar;14(5):415-28
pubmed: 17051251
Blood. 2007 Sep 15;110(6):1788-96
pubmed: 17495135
Blood. 2007 Dec 15;110(13):4144-52
pubmed: 17726165
J Virol. 2008 Jan;82(1):86-95
pubmed: 17959670
Nat Biotechnol. 2007 Nov;25(11):1298-306
pubmed: 17965707
J Clin Invest. 2008 Mar;118(3):935-45
pubmed: 18274668
Dev Cell. 2008 Aug;15(2):261-71
pubmed: 18694565
Dev Cell. 2008 Aug;15(2):272-84
pubmed: 18694566
Nat Methods. 2009 Jan;6(1):63-6
pubmed: 19043411
Mol Ther. 2009 Jun;17(6):1073-82
pubmed: 19259069
Curr Gene Ther. 2009 Apr;9(2):104-14
pubmed: 19355868
Adv Drug Deliv Rev. 2009 Jul 2;61(7-8):542-53
pubmed: 19393703
Blood. 2009 Dec 10;114(25):5152-61
pubmed: 19794140
Nat Med. 2010 Feb;16(2):198-204
pubmed: 20098431
Nature. 2010 Sep 16;467(7313):318-22
pubmed: 20844535
Immunotherapy. 2010 Sep;2(5):685-95
pubmed: 20874652
Cancer Gene Ther. 2011 Feb;18(2):87-99
pubmed: 20885451
Mol Ther. 2011 Jan;19(1):122-32
pubmed: 20978475
Sci Transl Med. 2010 Nov 17;2(58):58ra84
pubmed: 21084719
Mol Ther. 2011 Apr;19(4):723-30
pubmed: 21285959
Hepatology. 2011 May;53(5):1696-707
pubmed: 21520180
Hum Gene Ther. 2012 Jan;23(1):56-69
pubmed: 21877920
Cancer. 2012 Apr 1;118(7):1884-93
pubmed: 22009660
Blood. 2012 Feb 2;119(5):1107-16
pubmed: 22096239
Blood. 2012 Jun 7;119(23):5532-42
pubmed: 22368271
Mol Ther. 2013 Jan;21(1):175-84
pubmed: 22371846
Nat Rev Genet. 2012 Sep;13(9):613-26
pubmed: 22868264
Antiviral Res. 2013 May;98(2):305-13
pubmed: 23523766
PLoS One. 2013 Apr 23;8(4):e61412
pubmed: 23626683
Science. 2013 Aug 23;341(6148):1233151
pubmed: 23845947
Science. 2013 Aug 23;341(6148):1233158
pubmed: 23845948
Hum Gene Ther Methods. 2014 Feb;25(1):14-32
pubmed: 24090197
EMBO Mol Med. 2013 Nov;5(11):1684-97
pubmed: 24106222
J Thromb Haemost. 2014 Jan;12(1):36-42
pubmed: 24118899
Perspect Biol Med. 1985 Autumn;29(1):10-36
pubmed: 2415913
Int J Mol Sci. 2013 Nov 06;14(11):22011-21
pubmed: 24201130
Nat Immunol. 2014 Jan;15(1):54-62
pubmed: 24270517
Sci Transl Med. 2014 Jan 1;6(217):217ra3
pubmed: 24382895
Mol Biol Rep. 2014;41(4):2093-9
pubmed: 24420857
Mol Ther. 2014 Aug;22(8):1472-1483
pubmed: 24869932
Front Biosci (Landmark Ed). 2014 Jun 01;19:835-53
pubmed: 24896320
Mol Ther. 2014 Sep;22(9):1605-13
pubmed: 24954473
Cell Rep. 2014 Nov 20;9(4):1219-27
pubmed: 25456124
Mol Ther Methods Clin Dev. 2014 Apr 30;1:14013
pubmed: 25558460
Sci Transl Med. 2015 Mar 4;7(277):277ra28
pubmed: 25739762
Immunotherapy. 2015;7(3):271-84
pubmed: 25804479
Cancer Biother Radiopharm. 2015 May;30(4):160-8
pubmed: 25853522
JAMA. 2015 Apr 21;313(15):1550-63
pubmed: 25898053
Haematologica. 2015 Jul;100(7):881-92
pubmed: 25911555
Sci Transl Med. 2015 May 27;7(289):289ra81
pubmed: 26019217
Curr Protoc Mol Biol. 2015 Oct 01;112:26.1.1-5
pubmed: 26423588
Sci Rep. 2015 Nov 27;5:17166
pubmed: 26612671
J Immunol. 2016 Jan 1;196(1):17-21
pubmed: 26685314
Int J Mol Sci. 2016 Apr 06;17(4):502
pubmed: 27058529
J Thromb Haemost. 2016 Jun;14(6):1121-34
pubmed: 27061380
World J Exp Med. 2016 May 20;6(2):37-54
pubmed: 27226955
Biochem Biophys Res Commun. 2016 Sep 16;478(2):791-7
pubmed: 27501760
Mol Ther Methods Clin Dev. 2016 Sep 28;3:16064
pubmed: 27738645
Int J Mol Sci. 2016 Oct 13;17(10):
pubmed: 27754357
Sci Rep. 2016 Dec 08;6:38750
pubmed: 27929118
Hum Gene Ther. 2017 May;28(5):392-402
pubmed: 28056565
Science. 2017 Feb 10;355(6325):
pubmed: 28082412
Mol Ther. 2017 Aug 2;25(8):1815-1830
pubmed: 28552407
Medicine (Baltimore). 2017 Jun;96(22):e6825
pubmed: 28562533
Life Sci. 2017 Sep 15;185:8-14
pubmed: 28728902
N Engl J Med. 2017 Dec 28;377(26):2519-2530
pubmed: 29224506
Int J Mol Sci. 2018 Jan 16;19(1):null
pubmed: 29337905
Mol Brain. 2018 Feb 9;11(1):7
pubmed: 29426354
Leukemia. 2018 Jul;32(7):1529-1541
pubmed: 29654266
Cell Immunol. 2018 Apr 27;:null
pubmed: 29735164
Hum Gene Ther. 2018 Jul 23;:null
pubmed: 29890905
J Med Chem. 2018 Jul 11;:null
pubmed: 29993250
Cell Rep. 2018 Jul 10;24(2):294-303
pubmed: 29996091
Mol Ther Methods Clin Dev. 2018 Aug 04;10:268-280
pubmed: 30140714
Hum Gene Ther. 2018 Oct;29(10):1183-1201
pubmed: 30160169
Sci Rep. 2018 Oct 19;8(1):15539
pubmed: 30341383
Blood. 1972 Aug;40(2):234-8
pubmed: 4557986
Cell. 1993 Dec 3;75(5):843-54
pubmed: 8252621
Science. 1996 Apr 12;272(5259):263-7
pubmed: 8602510
Biol Chem Hoppe Seyler. 1996 Mar;377(3):195-201
pubmed: 8722321
J Virol. 1998 Dec;72(12):9873-80
pubmed: 9811723